Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium (Selenite) in Septic Shock
NCT00207844Phase 2Completed
- Sponsor
- Centre Hospitalier de Meaux
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in septic shock comparing Selenium with Placebo (2 arms). Primary endpoint: Weaning time of catecholamines. Started Jan 2002; status: completed.
02
Drugs
sodium selenite
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00207844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00207844.